Research map: Identification of a prognostic signature based on expression of post-translational modification-related genes in acute myeloid leukemia

Back to the article

Papers in this map

  1. The Genotype-Tissue Expression (GTEx) project. · 2013 · 10212 citations · Cited by this paper
  2. End-of-life cancer care quality in rural areas of Japan: an exploratory bereaved family survey · 2026 · Related
  3. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN · Hartmut Döhner · 2022 · 3298 citations · Cited by this paper
  4. Developing quality indicators for supportive care in cancer treatment: a modified Delphi method · 2026 · Related
  5. Targeted protein degradation: mechanisms, strategies and application · Lin Zhao · 2022 · 972 citations · Cited by this paper
  6. Hereditary cancer multigene panel testing in the United States and Europe: real-world constraints and implications for responsible integration in Japan · 2026 · Related
  7. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study · Naval Guastad Daver · 2018 · 579 citations · Cited by this paper
  8. A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART) · 2026 · Related
  9. Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complex · Enrico Brugnera · 2002 · 578 citations · Cited by this paper
  10. Resolution of peritoneal metastases in CLDN18.2-positive gastric cancer treated with CAPOX plus zolbetuximab · 2026 · Related
  11. The Roles of Post-translational Modifications in the Context of Protein Interaction Networks · Guangyou Duan · 2015 · 445 citations · Cited by this paper
  12. Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study · 2026 · Related
  13. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion · Anna Paczulla · 2019 · 406 citations · Cited by this paper
  14. Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint · 2026 · Related
  15. Pathological implication of protein post-translational modifications in cancer · Sheng Pan · 2022 · 269 citations · Cited by this paper
  16. A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY) · 2026 · Related
  17. Catch me if you can: how AML and its niche escape immunotherapy · Sarah Tettamanti · 2021 · 227 citations · Cited by this paper
  18. Age-standardized mortality-to-incidence ratio for lymphoma in the world · 2026 · Related
  19. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation · Yifat Geffen · 2023 · 212 citations · Cited by this paper
  20. Clinical utility of tumour markers in skeletal metastasis of unknown primary at the initial visit · 2026 · Related
  21. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment · Wen Li · 2021 · 203 citations · Cited by this paper
  22. GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system · Jean‐Marc Fritschy · 2014 · 200 citations · Cited by this paper
  23. Lupus nephritis: new progress in diagnosis and treatment · Yu Chen · 2022 · 196 citations · Cited by this paper
  24. The clinical impact of the molecular landscape of acute myeloid leukemia · Sabine C. Käyser · 2023 · 169 citations · Cited by this paper
  25. Uncovering post-translational modification-associated protein–protein interactions · Shu Wang · 2022 · 154 citations · Cited by this paper
  26. Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy · Sophia K. Khaldoyanidi · 2021 · 102 citations · Cited by this paper
  27. Post-translational modifications and their implications in cancer · Hashnu Dutta · 2023 · 92 citations · Cited by this paper
  28. GABAergic signaling beyond synapses: an emerging target for cancer therapy · De Huang · 2022 · 83 citations · Cited by this paper
  29. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development · Yiyi Yao · 2021 · 80 citations · Cited by this paper
  30. Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies · Luiza Handschuh · 2019 · 69 citations · Cited by this paper
  31. GABAergic signaling as a potential therapeutic target in cancers · Yihui Yang · 2023 · 65 citations · Cited by this paper
  32. Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies · Shifen Wang · 2023 · 59 citations · Cited by this paper
  33. Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia · Laura Barreyro · 2022 · 51 citations · Cited by this paper
  34. CAMKs support development of acute myeloid leukemia · Xunlei Kang · 2018 · 48 citations · Cited by this paper
  35. The CPNE Family and Their Role in Cancers · Haicheng Tang · 2021 · 42 citations · Cited by this paper
  36. Fusion of AML1/Runx1 to Copine VIII, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation · H. E. Ramsey · 2003 · 41 citations · Cited by this paper
  37. Targeting integrins in drug‐resistant acute myeloid leukaemia · Heather Anne N. Ogana · 2023 · 39 citations · Cited by this paper
  38. Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review · Charan Thej Reddy Vegivinti · 2023 · 37 citations · Cited by this paper
  39. High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia · Sze-Hwei Lee · 2017 · 36 citations · Cited by this paper

Source: OpenAlex (CC0)